Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/07/22
End: 08/31/27
Due: 08/31/28
Phase: N/A
Priority: Normal
Start: 09/03/19
End: 11/30/25
Due: 11/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors | NCT06245330 | Ascentawits Pharmaceuticals, Ltd | user2@example.com | None | 2022-07-07 | 2027-08-31 | 2028-08-31 | - | - | 2025-07-14 |
| A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors | NCT06239155 | Ascentawits Pharmaceuticals, Ltd | user2@example.com | None | 2019-09-03 | 2025-11-30 | 2026-11-30 | - | - | 2025-07-14 |